Keyphrases
Activation Level
20%
Allosteric Agonist
20%
Analgesic
20%
Anti-inflammatory Effect
20%
Attention Impairment
20%
Brain Regions
40%
Central Nervous System
20%
Choline
20%
Cholinergic Hypofunction
20%
Cholinergic Neurotransmission
20%
Cholinergic Tone
40%
Cognitive Impairment
20%
Cognitive Performance
20%
Cortex
20%
Differential Effectiveness
20%
Disease-related
20%
Existing Trends
20%
Hippocampus
20%
Increased Safety
20%
Injury Levels
20%
Injury Type
20%
Neurological Impairment
20%
Neuronal Damage
20%
Neuropathology
20%
Nicotinic Acetylcholine Receptor (nAChR)
40%
Nicotinic Agonists
20%
Nicotinic Receptors
100%
Non-neuronal Tissues
20%
Orthosteric
20%
Penumbra
20%
Positive Allosteric Modulation
100%
Positive Allosteric Modulator
80%
Rational Basis
20%
Safety Self-efficacy
20%
Selective Agonist
20%
Therapeutic Promises
100%
Therapeutic Use
40%
Trauma Symptoms
20%
Neuroscience
Agonist
40%
Anti-Inflammatory
20%
Central Nervous System
20%
Choline
20%
Cholinergic
60%
Cholinergic Transmission
20%
Cognitive Disorders
20%
Hippocampus
20%
Nicotinic Acetylcholine Receptor
40%
Nicotinic Agonist
40%
Nicotinic Receptor
100%
Positive Allosteric Modulator
80%
Pharmacology, Toxicology and Pharmaceutical Science
Analgesic Agent
14%
Antiinflammatory Activity
14%
Choline
14%
Cholinergic Receptor Stimulating Agent
57%
Cognitive Defect
14%
Disease
14%
Injury
71%
Nicotinic Agent
28%
Nicotinic Receptor
100%
Positive Allosteric Modulator
57%
Therapeutic Use
14%